Professional Documents
Culture Documents
LF-62 Toxicology of Solar Heat Transfer Fluids - Literature
LF-62 Toxicology of Solar Heat Transfer Fluids - Literature
LF-62 Toxicology of Solar Heat Transfer Fluids - Literature
Category: UC-48
February 1979
C. R. Clark
T. C. Marshall
T. R. Henderson
A. Sanchez
C. H. Hobbs
LOVELACE
ENVIRONMENTAL
P,O.
BOX 5890
BIOMEDICAL
RESEARCH
Albuquerque,
and
INSTITUTE
NM 87115
NOTICE
This report was prepared as an account of work sponsored
by the United States Government. Neither the United States
nor the United States Department of Energy, nor any of their
employees, nor any of their contractors,
subcontractors,
or
their employees, makes any warranty, expressed or implied,
or assumes any legal liability
or responsiblity
for the
accuracy, completeness or usefulness of any information,
apparatus, product or process disclosed, or represents that
its use would not infringe privately
owned rights.
Printed
From
LF-62
Category:
UC-48
TOXICOLOGY
OF SOLARHEAT TRANSFER
FLUIDS: LITERATURESURVEYANDEVALUATIONOF MUTAGENIClTY
AND EFFECTON ARYL HYDROCARBON
HYDROXYLASE
ACTIVITY
C.
T.
T.
A.
C.
Inhalation
Toxicology
Research Institute,
R. Clark
C. Marshall
R. Henderson
Sanchez
H. Hobbs
Research Institute,
February 1979
ACKNOWLEDGMENT
The authors wish to acknowledge the cooperation
fluid
of the manufacturers
TABLE OF
CONTENTS
ACKNOWLEDGEMENTS
.............................................................................
iii
LIST OF TABLES..............................................................................
EXECUTIVESUMMARY
...........................................................................
INTRODUCTION
................................................................................
LITERATURESURVEY...........................................................................
Silicone
Oils ..........................................................................
Miscellaneous
Fluids
...................................................................
EVALUATIONOF SOLARHEATTRANSFER
FLUIDS FORMUTAGENICITY
...................................
Materials
A.
Heat Transfer
Fluids
B.
Preparation
and Culturing
C.
Preparation
of Liver
D.
Bacterial
E.
Controls
Mutagenicity
and Quality
..........................................................
of Tester Strains
Homogenate (S-9)
Assay ....
...................................
.........................................
...............................................
Assurance ................................................
.................................................................
INFLUENCEOF SOLARHEATTRANSFER
FLUIDS ON HEPATICARYL HYDROCARBON
HYDROXYLASE
ACTIVITY ..................................................................................
Materials
5
6
6
6
6
7
7
7
7
10
10
A.
10
B.
10
C.
D.
12
12
12
REFERENCES
..................................................................................
13
APPENDIX....................................................................................
16
ii
LIST OF TABLES
Page
Heat Transfer Fluids Proposed for Use in Residential
Table 2.
Mutagenicity
Table 3.
Typical
Table 4.
Mutagenicity
11
Tab1e 5.
AHHActivity
12
Fluids .......................................
iii
Controls
............................
.....
Table 1.
8
10
MUTAGENICITY
AND EFFECTON ARYLHYDROCARBON
HYDROXYLASE
ACTIVITY
C. R. Clark,
T. C. Marshall,
applications,
scrutinized
in active
technology
is resulting
their
use in residential
hazards.
solar
literature
include
and miscellaneous
fluids.
that its
of acute exposure.
are the results
constructed
studies.
fluids
used
(petroleum
of two in vitro
screening procedures.
silicone
class of fluids
glycol.
of producing positive
toxic
energy applications
the potential
of heat trans-
distillates),
than ethylene
of Salmonellatyphimurium.It
category
is approximately
for
strains
report.
hydrocarbon oils
Propylene glycol
on the toxicology
in the miscellaneous
of this
Ethylene glycol
based formulations.
Also reported
portion
acute (single
Several fluids
large portion
tected
into
toxicologically
for information
fer fluids
specially
Of particular
table
of new materials
oils
i~ the introduction
results
as an initial
in animal carcinogenesis
toxicological
screen.
Twenty-
collectors
ability
reported
in progress will
enhanced this
were evaluated
metabolic
systems
most likely
path-
metabolic
of the material
major constituent
(AHH), an important
significantly
provide
hydrocarbon hydroxylase
being
at risk
being evaluated.
INTRODUCTION
useful
of residential-
sized buildings.
The current use of solar energy to heat and cool residences is very limited.
However, it is expected to increase markedly over the next few years. One report I estimates that solar
energy could provide
to Congress on April
of this
and goals,
new technology
for installation
homes by 1985.
be associated
is necessary.
of
The
of materials,
potential
for
toxicity
tial
effects
on human health
of materials
is essential
that an evaluation
of the poten-
to
of this
study is to identify
proposed for
It
which materials
from a standpoint
Of the
high
potential
for hazard to man. Information
from industrial
research and development groups and from
a solar energy handbook published by Sandia Laboratories 2 aided us in identifying
heat transfer
fluids
in Table I. A list
find
of manufacturers
solar
applications.
Samples provided
by manufacturers
are listed
Table 1
Heat Transfer
Commercial Name
Silicone
Use in Residential
Manufacturer
Composition
Oils
General Electric
Dow-Corning
Polydimethylsiloxanes
Mobiltherm Light
Mobil Oil
Paraffinic,
high aromatic
Mobiltherm 603
Mobil Oil
Paraffinic,
neutral
Suntemp
Paraffinic,
low aromatic
Exxon Corporation
Paraffinic,
low aromatic
Exxon Corporation
DowChemical
Ethylene glycol
and inhibitors
UCARThermofluid-17
Union Carbide
Ethylene glycol
and inhibitors
Dowfrost
DowChemical
Propylene glycol
and inhibitors
Camco
Propylene glycol
and inhibitors
Freeze Proof
CommonwealthChemical
Propylene glocol
and inhibitors
UCARFood Freeze 35
Union Carbide
Propylene glycol
and inhibitors
Nutek 835
Sunsol60
Sunworks
Propylene glycol
UCON50-HB-280X
Union Carbide
Polyalkylene
glycol
UCON500
Union Carbide
Polyalkylene
glycol
SF-96
DC Q2-1132
Polydimethylsiloxanes
Hydrocarbon Oils
Caloria
HT-43
oil
Glycols
Dowtherm SR-I
and inhibitors
and inhibitors
Miscellaneous
Nutek 876
Nuclear Technical
Corporation
Concentrated inhibitors
Virco Pet 30
Mobil Chemical
Therminol 66
Monsanto
Terphenyls mixture
Dowtherm A
DowChemical
Diphenyl/diphenyl
Drewsol
Polyhydroxy-organic
Solargard G
Daystar Corporation
Glycerol/water
oxide
The likelihood
that tests
these tests
ical
portion
information
at this
of this
of aryl
time.
report
on the materials.
water (via
are incomplete
The first
of potable
bacterial
mutagenicity
contains
findings
Also included
in this
(AHH) activity.
toxicological
assay utilizing
evaluation
specially
both frameshift
normally surrounding
rapid,
of the strains
deficient
agar plates
capable of synthesizing
reproducible
and yields
results
histidine
results
Those fluids
containing
ability
enzyme responsible
excision
genes (R-factors)
Incubation
of the histidine
is inexpen-
potential,
i.e.,
major constituent
(AHH) activity.
with most
auxotrophs to
repair
further
of the strains
scored.
capa-
deficient
in animal studies
hydrocarbon hydroxylase
and induc-
wall,
in the reversion
which correlate
of in vitro
(Ames) test
is a
5
of 5~Imonellatyphi~rium.
resistance
to induce aryl
cell
events.
for their
of a series
type mutations.
antibiotic
to mutational
for toxicolog-
biosynthetic
the bacterial
literature
strains
Results of
3,4
elsewhere.
are results
in animal test
constructed
report
These tests
ble of detecting
barrier
are published
Mutation-induced
lipopolysaccharide
be performed.
hydrocarbon hydroxylase
materials
Preliminary
and main-
were further
evaluated
of polynuclear
aromatic
cigarette
i.e.,
the activity
in either
by the inducer.
chemical carcinogenesis
it
certain
is usually
or detoxification
Induction
was of interest
aromatic constituents
of a wide variety
increased activation
of enzymes affected
taining
of chemicals including
smoking, etc.
to induce this
fluids
con-
enzyme.
LITERATURESURVEY
This section
cological
summarizes information
information
commercial preparations
studies
materials
relevant
fluids.
no information
is available
data is available
Only those
manufacturers
Practically
literature
in solar
evaluations
glycol
food processing
comprised the
and medical ap-
fluids;
the silicone
oils
fluids
containing
of the projects
ethylene
or propylene glycol
under investigation
of considerable
toxicological
due to their
as drug solvents,
food additives
and anti-freezes.
glycol
is more toxic
glycol
as a I to 4% dietary
supplement for their life span have demonstrated that the compound is more toxic to males than
females. 1314 This difference is most likely
due to a variance in the metabolic disposition
of
ethylene glycol centering around the extent of oxalate formation. 15 A similar explanation of the
observed interspecies
susceptibility
to ethylene glycol poisoning
by experimental evidence. 1116 The most notable histopathological
sure in rats and monkeys was marked kidney damage, with the former species also demonstrating slight
lung and liver anomalies. 1317-19 The highest no-effect level of ethylene glycol in the diet of
rats was reported as 0.2%. 18 None of the above-mentioned chronic studies, as well as a lifetime
exposure to subcutaneous injections
Repeated and continuous
been conducted in rats,
of this
inhalation
rabbits,
glycol
to rats,
have indicated
any carcinogenic
potential.
guinea pigs,
hours per day for 6 weeks) resulted in mild to severe eye irritation
in rodents and spleen congestion
in dogs, but no deaths in any species. Ninety-day continuous exposures (12 mg/m3) caused moderate
to severe eye irritation
and inflammatory
Humanvolunteers
8 days. Deaths
(actual lengths of exposure per day was not stated) complained of mild headache and backpains and
22 At concentrtaions
throat irritation.
of 250-300 mg/m3 volunteers could not tolerate
a single
3
3
breathing cycle. A threshold limit
valve (TLV) of i0 mg/m for the mist and 250 mg/m of the vapor
has been set. 23 These values represent
workers may be repeatedly
to which nearly
all
adverse
effects.
The maximumconcentration to which workers can be exposed for a period of up to 15 minutes
(short-term
exposures limit or STEL) has been set at 20 mg/m3 for the mist and 325 mg/m3 for the
vapor. 23 The value of 325 mg/m3 for the vapor does not appear adequate in view of the inability
of
3.
the volunteers in the above study to tolerate
an atmosphere of 250-300 mg/m The low vapor concentration
of ethylene glycol
perature;
is possible
Propylene glycol
temperatures encountered.
an increase
bilirubin,
however, no histopathological
no effect
were found.
2O
Hydrocarbon Ogl;~
Heat transfer
fluids
in this
paraffinic
is complicated
of crude oil.
classified
that their
Detailed
characterization
composition will
as
(40%
and toxicological
evalua-
SgZ.icone
Oils
Silicone
oils
fluids
are linear
polydimethylsiloxanes
24-hour LD50s are reported by the manufacturer to range from 30 to 50 ml/kg and higher, indicating
low toxicity. 29 The rat i.v. 24-hour LD50 for Dow-Corning 200 (a PDMS)is 500 mg/kg, which is about
0.5 ml/kg. 30 The large discrepancy between oral and systemic toxicities
can be accounted for by
data which show that PDMSis poorly absorbed from the gastrointestinal
tract. 30 Polydimethylsiloxanes
caused a temporary conjunctival
irritation
when instilled
into the eyes of rabbits, a response also
observed in humans.31 When applied to intact and abraded rabbit skin, a series of PDMSwere not
irritating
and apparently
hexamethyldisiloxane
at a vapor
of PDMSsubchronic
(1.0-2.5% dietary
disagreeable
odor. A
80 weeks; 1%
or no observable
toxicity
or pathology.
No fetotoxicity
or teratogenicity
was reported
among
the offspring of rats and rabbits administered 200 to I000 mg/kg of a PDMSpreparation for 2 to 3
weeks. 32 The toxicity
of PDMSvapors is of limited interest
because of their low vapor pressure
but much attention
of their
use in cosmetic,
extensive
valves in active
solar
studies
spray formulations.
Vapors or mists
of a 5% aerosol
of PDMSand their
high resistance
of PDMSinto
to biodegradation
the environment.
by microorganisms,
A recent report
and water,
stated
MiscellaneousFluids
Several heat transfer
cations.
fluids
Therminol 66 is described
do not readily
by its
fit
into
manufacturer
nephritis),
terphenyl
mentioned classifipreparation.
Chronic
of terphenyls
(Santowax OM) to
anemia and weight loss. 34 Exposure of
mice to an aerosol of ortho-, para- and meta-terphenyls mixture (mean concentration 0.5 mg/L, particle size 8 4 pm) produced no gross lung injury. 35 Many Type II epithelial
cells showed central
to the
of terphenyls
to their
composition of ortho,
meta and
para isomers since these possess rat oral LD50s of 1900, 2400 and greater than 10,000 mg/kg, respectively. 38 Inhalation
exposure of eight rats each to mean concentrations of about 3.5 g/m3 for I
hour resulted
14 36
days.
Dowtherm A is a mixture
of diphenyl
the ortho-,
respectively
after
exposure
oxide
24-hour oral LD50 of diphenyl oxide was reported to be 3.37 g/kg and acute
dermal LD50 as > 5 g/kg. 42 In humans, exposure to 7-10 ppm of a eutectic mixture of diphenyl/diphenyl
oxide vapors was extremely nauseating and painful to the eyes and upper respiratory
tract. 43 It is
not likely
odor of Dowtherm
A is apparent at concentrations
adduct. Manufacturers
data lists
the rat 24 hour oral LD50 at 6830 mg/kg, and states that rats tolerated an inhalation exposure of
44 Irritancy
23 mg/L for i hour without lethality.
studies in rabbits generated an eye score of
29/110 at 24 hours and primary
44
irritant.
classifying
and diluted
available
heat transfer
in dimethylsulfoxide
fluids
(DMSO, spectral
quality)
Preparation
collectors.
Concentrations
for
evaluation.
10 days to simulate
tested
stagnation
were
conditions
plate.
and Culturing
of Tester Strains
(Table 1)
mMbiotin
added after
cooling
prior
SalmonelLa typhim~ri~n
strains
by
C.
Preparation
.of Liver
Homogenate(S-9~
colony) treated
with
were excised and homogenized in ice cold 1.15% KCI 5 days after
for
and quickly
(S-9)
prior
treat-
collected,
to use and
mixed with an appropriate amount of cofactor solution (8 mMMgCl2, 33 mMKCl, 5 mMglucose-6phosphate, 4 mMNADP) in 0.2 M phosphate buffer (pH 7.4) and filter
sterilized
(0.45 ~m Millipore
filter).
metabolic
activation,
per ml cofactor
D.
Bacterial
Mutaqenicity
Maximumreversions
solution).
Assay
by Ames ~t al. 5 Test tubes containing
agar were kept in a 45~C water bath. To 2 ml of the agar, 0.1 ml bacterial
test
E.
tested.
Controls
saline
dish containing
After
strains:
it
suspension,
incubating
top
0.I
and Quality
ml
and
were evaluated
48 hours colonies
were counted
Assurance
controls
N-methyl-N-nitro-N-nitrosoguanidine
(9-AA; I0 l~g/plate
2 ml soft
cell
to maximize reversions
solution
(2-AF, I0 ug/plate
in ethanol,
(MNNG,10 ~ig/plate
properties
dissolved
of the
in DMSO,TA-1535
metabolic
activation
to express
saline
and layering
to controls
(DMSOsubstituted
The saline,
plates
for test
on nutrient
agar plates.
of direct
cytotoxicity.
agar
~esuIL.sand Discussion
Despite a certain
generally
amount of controversy
For this
reason, it
strains
is extremely
important
can result
of Ames test
reported
in an initial
fluids
were evaluated
in Table 2, indicate
it
controls
different
sensitivity.
or loss of the
ug/plate.
is
properties
The remutagenic
of the tester
established
it
results
is desirable
screen,
results,
number of revertants
sults,
interpretation
surrounding
rates were
Table 2
Mutagenicity
~_~te~
Fluids
Number of Revertants
(Without-With Metabolic aActivation)
S. typhimur<~zStrain
TA-1537
TA-1538
TA-98
TA-1535
135-111
111-112
110-128
145-128
SF-96
0
10
100
1000
22-13
7- 7
12- 7
8- 7
7-18
5-10
7-10
5- 7
9-33
9-38
9-35
7-36
18-57
11-39
20-41
22-50
Mobiltherm Light
0
I
10
100
i000
12-16
7- 9
6- 0
O- 0
O- i
12-15
2- 2
3- 2
3- 2
O- 3
9-18
3~23
2- 5
O- 0
5-16
11~17
23-46
0-19
13- 0
26-28
Mobiltherm 603
0
1
10
100
1000
19141277-
8-10
4- 7
6- 7
4- 7
8- 9
6-42
6-33
16-30
9-31
8-12
12~39
16-50
15-46
21-40
16-22
7
9
5
5
5
11-36
12-27
9-34
14-17
25-14
15-45
20-48
21-37
13~25
26-21
i17-121
134-122
143-130
102-120
127-120
9-33
7-45
7-37
3-39
18-57
11-40
16-34
16-37
135-111
101-109
97- 96
85- 96
117-121
133-133
121-151
116-132
98-136
Suntemp
7
5
8
8
4
5101169-
0
10
100
I000
i0000
22-17
20- 9
28-11
20-10
-
0
10
i00
I000
22-13
17- 5
21-12
12- 6
7-18
8- 5
6- 4
5- 7
0
10
100
i000
10000
22-17
19-10
26- 9
24-10
13-11
59566-
7
8
9
4
6
11-36
10-38
10-27
9-14
9-17
15-45
19-37
20-36
17-27
16-13
Dowtherm SR-1
0
I
10
i00
1000
12-16
7- 5
7- 3
5- 4
3- 7
12-15
2- 8
5- 5
2- 5
5- 7
9-18
8-31
8-45
8-29
7-23
11-17
20-55
31-46
25-35
17-40
UCARThermofluid-17
0
1
10
i00
I000
19- 7
16- 8
10-12
6-10
9- 7
8-10
8-11
7- 5
8- 8
6- 5
6-42
5-41
8-24
6-33
9-21
12-39
7-18
6-40
9-45
13-54
Dowfrost
0
1
10
i00
I000
12-16
7- 5
8- 6
8- 8
i0- 5
12-15
4- 5
3- 9
O- 0
O- 6
9-18
3-22
5- 8
3- 0
7-24
11-17
23-59
18~50
24-42
8-37
0
100
1000
7- 6
4- 2
8- 8
3- 7
3- 4
4- 5
6-12
2-12
10-13
9-24
14-28
19-15
Freeze Proof
0
100
1000
7- 6
8- 4
6- 5
2- 7
3- 3
1- 2
6-12
5-10
4- 6
9-24
13-18
13-17
Caloria HT-43
Table 2 (Continued)
Number of Revertants
a
(Without-With Metabolic Activation)
s. typhim~ium Strain
TA-1537
TA-1538
TA-98
ug/Plate b
TA-1535
UCAR-35
0
1
10
I00
1000
19- 7
13- 7
9- 6
14-10
16-12
8-10
44 4
6- 4
9-11
5- 7
6-42
9-36
9-28
9-46
12-45
12-39
18-50
19-54
21-64
19-59
Nutek 835
0
10
100
i000
10-12
13-13
16-13
13-12
17-39
19-15
13-35
17-33
25-63
30-58
32-62
31-57
174-156
173-169
185-171
174-173
Sunsol 60
0
100
1000
7- 6
5- 4
8- 6
3- 7
3- 2
24 2
6-12
6-12
3-13
9-24
10-22
7-17
126-142
127-137
143-143
UCON-50
0
10
100
1000
UCON-500
0
1
10
100
I000
19- 7
17- 7
18-11
12- 7
ii- 7
8-10
7- 7
9~ 7
6- 5
i- 5
6-53
14-43
12-30
8-32
15-17
23-39
20-54
19-49
21-42
18-26
Nutek 876
0
10
100
1000
10-12
15-18
10-18
14-11
17-39
20-42
11-37
11-58
25-63
24-57
21-55
14-50
Heat Transfer
Fluid
9-33
10-20
6-36
4-12
TA-IO0
135-111
97-105
95- 58
113- 97
174-156
172-172
167-179
176-182
Virco Pet-30
0
100
1000
7- 6
7- 4
8- 8
3- 7
5- 4
3- 5
6-12
5- 7
5-11
9-24
7-10
13-22
Therminol 66
0
10
100
I000
22-13
27~ 8
27- 8
I0- 8
7-18
9- 7
8- 7
10- 9
9-33
7-45
9-21
16-23
18-57
11-28
12-28
16-28
135-111
127-134
107-139
111-113
7
6
5
5
0
11-36
10-29
13-26
4-16
O- 0
15-45
17-39
11-36
12-24
O- 0
117-121
135-124
96-130
66- 62
42- 53
126-142
133-138
128-143
Dowtherm A
0
10
I00
I000
I0000
5743O-
Drewsol
0
100
1000
7- 6
10- 4
12- 5
3- 7
4- 2
3- 2
6-12
6-16
3-12
9-24
12-16
10-12
Solargard G
0
100
1000
7- 6
6- 5
8- 8
3- 7
3- 5
1- 3
6-12
2- 5
I- 4
9-24
13-17
ii-II
aMetabolic
activation
bDosage indicated
by Aroclor
was delivered
microsomal preparations.
Table 3
a
Typical
Spontaneous
Revertants
Number of Revertants
Salmonella
ty,ph<rr~r<um
Strain
TALl537
TA-153B
TA-IOO
TA-1535
20
160
25
175
MNNG(10 ~g)
> 2000
> 2000
200
> 1000
Saline
b
s-g
reversion
properties
microsomal preparations
Controls
of tester
T--AZ-g~-.
25
40
40
55
> I000
70
90
> 2000
> 2000
7
I0
strains.
from Aroclor-1254
induced rats.
Virco Pet-30, Mobiltherm Light and Dowtherm A were toxic to the tester strains at the higher
-6
doses. Mobiltherm Light and Dowtherm A caused 75% and 100% cell death to the tester strains (10
dilution),
respectively,
at I000 ~g/plate.
No mutagenicity was observed at doses which were not
44
toxic. Virco Pet-30 was reported to be negative in the Ames test by other investigators.
Ten fluids
not flowing
were subjected
to heating
at 232C to simulate
indicating
materials
fluids
(copper,
temperatures
is
Color
aluminum, etc.)
and it
is anticipated
of the fluids
when heated
projects
will
heat
be evaluated chem-
and toxicologically.
The results
reported
(or carcinogenicity).
fluids
Salmonella
induced by all
mutagens. In addition,
highly
specific
Ames testing
mutational
of complex
Roomtemperature
Allied
Chicago, IL),
heat transfer
AHHinducer),
B.
or saline
(0.2 ml).
fluid
aspen
(12L:12D).
fluids (Table 5)
intraperitoneally
treatment
by decapitation.
Enzyme Source
Livers were excised,
weighed and homogenized in 3 volumes of ice cold 1.15% KCI and centri-
10
concen-
Table 4
Mutagenicity
Heat Transfer
~g/Plate c
Fluid
TA-1535
Number of Revertants
b
,(Without-With Metabolic Activation)
s, typhimu~uln Strain
T--A~-i53~/
TA1538
TA-98
TA-IO0
UCON500
0
1
10
i00
I000
45-14
31-13
60-12
41-14
51-10
16-15
17-17
24-16
20- 8
15-14
13-37
12-56
17-46
14-37
15-14
23-53
19-60
19-56
29-54
17-40
187-116
150-113
144- 86
136-114
139- 91
UCON5O
0
I
10
I00
i000
45-14
43-16
47- 9
49-15
49-11
16-15
20-19
16-14
27-14
16-11
13-37
6-25
14-33
8-31
17-20
23-53
24-54
26-53
28-44
18-34
187-116
139-124
148-120
145-122
160-124
Suntemp
0
1
i0
i00
I000
45-14
44-14
51-17
46-15
46-16
16-15
12-14
32-13
24-12
25-10
13-37
13-31
16-35
8-36
12-17
23-53
27-46
27-43
30-55
24-38
187-116
151-123
150-143
170~I02
125- 97
Mobiltherm 603
0
1
10
I00
I000
45-14
46-14
32-10
37-13
35-14
16-15
27-9
24-12
25- 9
17- 9
13-37
13-30
12-44
11-37
12-22
23-53
19-53
21-50
27-50
27-33
187-116
157- 91
134- 87
161-120
148-122
0
10
100
I000
I0000
9122OO-
7
9
5
0
0
10-13
7-10
2- 8
O- 0
O- 0
7-40
8-41
11-27
O- 0
O- 0
9-37
8-39
8-31
4-26
O- 0
152-141
118-119
73- 72
17- 41
O- 0
Mobiltherm Light
0
10
100
i000
I0000
9595O-
7
5
3
i
0
10-13
8- 9
5-10
6- 7
O- 0
7-40
10-21
11-23
7-41
O- 0
9437
12-34
10-37
8-39
O- 0
152-141
90-150
73-159
53-108
O- 0
Therminol 66
0
i0
100
1000
10000
8- 7
10- 4
8-11
ii- 5
6- 2
10-13
5- 5
6-11
6- 3
3- 3
7-40
6-30
9-22
10-14
7-12
9-37
13-32
12-16
11-18
5-23
152-141
125-130
117-154
123-116
132-161
UCAR-17
0
I0
100
i000
i0000
14-10
24-11
15-11
17-15
20-10
14-33
14-33
15-33
13-31
12-43
185-111
116- 92
128- 97
103- 88
119- 99
0
10
100
1000
10000
19~I0
17-14
20-15
13-13
16-10
14-33
13-31
16-34
11-19
11-26
185-III
126-123
119-110
114-118
120- 73
0
10
i00
I000
I0000
19-10
19-18
24-23
17-22
25-26
14-33
15-36
16-45
16-40
14-37
185-111
121- 84
127- 30
111-115
113-117
Jowtherm A
SF-96
aFluids
bMetabolic activation
CDose indicated
delivered
liver
in 0.I ml DMSO.
11
microsomal preparations.
Table 5
C.
AHHActivity
After Treatment with Solar
a
Heat Transfer Fluids
A stock solution
was diluted
n moles
product/min/mg
Protein
Mean s.d.
Treatment
3H-Benzo(a)pyrene Substrate
tivity
of 3H-BAP (= 25 Ci/mM)
of 30 mCi/mmol, dissolved
and extracted
five
KOH/DMSO
(15/85;
v/v)
to eliminate
contaminants.
0.8 0.I
Dowtherm A
Mobiltherm 603
1.0 0.3
b
2.9 0.7
b
1.2 0.I
Suntemp
0.8 0.I
Caloria HT-43
0.9 + 0.2
Therminol 66
0.9 0.I
b
3.1 0.3
Mobiltherm Light
Aroclor 1254
(positive control)
and the
of 0.08
Assay
enzyme preparation
cate incubations
of each liver
homogenate were
ac-
in i00 ml hexane
Tris
buffer
(50 mM, pH
3H-BaP (0.08 mMdissolved in I0 ul acetone), bovine serum albumin (0.8 mg/ml) and
in 0.1 ml KCI. Blank values were obtained by running the assay in the absence of
enzyme.
The reaction was stopped by the addition of I ml KOH(0.15 M in 85% DMSO)and the unmetabolized
3H-BaP was extracted (3 x 5 ml with hexane). The aqueous phase (0.5 ml) was transferred
to a scintillation
vial
containing
by liquid
tion counting of the samples for I0 minutes were converted to nanomoles total metabolite
specific activity
of 3H-BaP substrate) and expressed as nanomoles formed/min/mg protein.
scintilla(based on
Resultsand Discussion
The six commercial heat transfer
oils
(Mobiltherm
Caloria
Light,
fluids
tested included
The AHHactivity
measured in liver
microsomal preparations
were significantly
of this
fluids,
in preparations
aromatic
(Dowtherm
resulted
animals.
and untreated
ani-
with Mobiltherm
measured in untreated
in the highest
AHH activity
activation
of the induction
fluids
only an ability
three distilled
of aryl
makes it
potential
hydrocarbons.
an important
of the
The key
enzyme to
or detoxification
study.
12
REFERENCES
1.
Carter, L. J., "Policy ReviewBoosts Solar as a Near-TermEnergy Option," Science 203: 252-253,
1979.
2.
3.
Marshall, T. C., C. R. Clark and C. H. Hobbs, "Acute Oral Toxicity of Solar Heat Transfer Fluids
in Rats," Inhalation Toxicology ResearchInstitute Annual Report, 1977-978, LF-60, pp. 441-444.
Ames, B. N., J. McCannand E. Yamasaki, "Methods for Detecting Carcinogens and Mutagenswith
the Salmonella/mammalian-microsome
mutagenicity test. Mutat. Res. 31: 347-364, 1975.
6.
8.
i0.
Clay, K. L. and R. C. Murphy, "On the Metabolic Acidosis of Ethylene Glycol Intoxication,"
Toxicol. Appl. Pharmacol. 39: 39-49, 1977.
11. McChesney,E. W., L. Golberg and E. S. Harris, "Reappraisal of the Toxicology of Ethylene
Glycol. IV. The Metabolism of Labelled Glycollic and Glyoxylic Acids in the RhesusMonkey,"
Food. Cosmet. Toxicol. 10: 655-670, 1972.
12. McDonald,T. 0., K. Kasten, R. Hervey, S. Gregg and B. Britton, "Acute Ocular Toxicity for
Normal and Irritated Rabbit Eyes and Subacute Ocular Toxicity for Ethylene Oxide, Ethylene
Chlorohydrin and Ethylene Glycol," Bull. Parenter. Druq Assoc. 31: 25-32, 1977.
13. Morris, H. J., A. A. Nelson and H. O. Calvery, "Observations on the Chronic Toxicities of
Propylene Glycol, Ethylene Glycol, Diethylene Glycol, Ethylene Glycol Mono-Ethyl Ether, and
Diethylene Glycol Mono-Ethyl Ether," J. Pharmacol. Exp. Ther. 74: 266-273, 1942.
14 Hanzlik, P. J., W. S. Lawrence and G. L. Laqueur, "Comparative Chronic Toxicity of Diethylene
Glycol Monoethyl Ether (Carbitol) and SomeRelated Glycols: Results of Continued Drinking and
Feeding," J. Ind. Hyg. Toxicol. 29: 233-241, 1947.
15.
Richardson, K. E., "EndogenousOxalate Synthesis in Male and Female Rats," Toxicol. Ap~l.
Pharmacol. 7: 507-515, 1965.
16.
17.
Blood, F. R., G. A. Elliott and M. S. Wright, "Chronic Toxicity of Ethylene Glycol in the
Monkey," Toxicol. Appl. Pharmacol. 4: 489-491, 1962.
18.
19.
20.
Mason,M. M., C. C. Cate and J. Baker, "Toxicology and Carcinogenesis of Various Chemicals Used
in the Preparation of Vaccines," Clin. Toxicol. 4: 185-204, 1971.
13
21.
22.
Committee on Threshold Limit Values for Substances in Workroom Air, "Documentation of Threshold Limit Values," American Conference of Governmental Industrial
Hygienists, 3rd Edition,
Cincinnati,
OH, 1971.
23.
24.
Phillips,
L., M. Steinberg, H. I. Maibach and W. A. Akers, "A Comparison of Rabbit and Human
Skin Response to Certain Irritants,"
Toxicol. Appl. Pharmacol. 21: 369-382, 1972.
25.
26.
27.
Weil, C. S., M. D. Woodside, H. F. Smyth, Jr. and C. P. Carpenter, "Results of Feeding Propylene
Glycol in the Diet to Dogs for Two Years," Food Cosmet. Toxicol. 9: 479-490, 1971.
28.
29.
30.
31.
32.
33.
Hobbs, E. J.,
Environmental
34.
35.
36.
37.
38.
39.
40.
41.
42.
Opdyke, D. L. J.,
1974.
Inc.
of the Silicones,"
Dow Cornings
of
of SomeCon~nonly Used
The Bulletin,
Vol. II:
of Polydimethylsiloxanes
of Polyphenyl Mixtures,"
14
National
Aspects
4: 15-16,
in Certain
of Reactor Polyphenyls
on
Nephrotoxic Effects
12: 703-736,
of
43.
44.
45.
46.
Van Cantfort,
Hydroxylase:
512, 1977.
Senior Toxicologist,
15
APPENDIX
MANUFACTURERS
PROVIDING HEAT TRANSFERFLUID SAMPLESFOR TOXICOLOGICAL EVALUATION
CAMCO
MANUFACTURING,
INC.
2804 Patterson Street
Greensboro, NC 27407
(Mr. Don Caine)
SOLARWINTERBAN
GENERAL
ELECTRICCOMPANY
SILICONESDIVISION
Waterford, NY 12188
(Dr. John Nair)
SF-96
COMMONWEALTH
CHEMICAL
1052 Gorham Street
Lowell, MA 01852
(Mr. Marry Paulson)
FREEZEPROOF
DAYSTAR
CORPORATION
90 Cambridge Street
Burlington,
MA 01803
(Mr. Jim Hall)
SOLARGARD-G
DOWCHEMICAL,USA
2020 Dow Center
Midland, MI 48640
(Dr. Paul J. Moses)
DOWEROST
DOWTHERM
SR-1
DOWTHERM
A
MONSANTO
INDUSTRIALCHEMICALS
COMPANY
1401 Dove Street
Newport Beach, CA 92663
(Mr. Ken Brakebill)
THERMINOL
66
NUCLEARTECHNOLOGY
CORPORATION
P. O. Box 2, Rt. 85
Amston, CT 06231
(Dr. Dennis Jakiela)
NUTEK835
NUTEK876
DOWCORNINGCORPORATION
Biological Services
2020 Dow Center
Midland, MI 48640
(Dr. Charles L. Groh)
DC Q2-1132
RESOURCE
TECHNOLOGY
CORPORATION
151 John Downey Drive
New Britain,
CT 06051
(Mr. Don Caine)
SUNTEMP
DREWCHEMICALCORPORATION
1 Drew Chemical Plaza
Boonton, NJ 07006
(Dr. Elliott
J. Levi)
DREWSOL
SUNWORKS,
DIVISION OF ENTHIONE,INC.
P. O. Box 1004
New Haven, CT 06508
(Ms. Ruth Smith.)
SUNSOL-60
EXXONCORPORATION
Marketing Technical Services
P. O. Box 2180
Houston, TX 77001
(Dr. Thomas G. Lipscomb)
PROCESS
OIL 3029
CALORIAHT-43
UNIONCARBIDE
17 Executive Park Drive
Atlanta, GA 30359
(Dr. Sam Livengood)
UCARFOODFREEZE35
UCARTHERMOFLUID
17
UCON50-HB-280-X
UCON5OO
PROPYLENE
GLYCOL,USP